Capricor Therapeutics, Inc. (CAPR)
24.72
+1.69
(+7.34%)
USD |
NASDAQ |
Feb 06, 16:00
24.72
0.00 (0.00%)
After-Hours: 20:00
Capricor Therapeutics SG&A Expense (TTM) : 21.94M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 304.67M |
| Inovio Pharmaceuticals, Inc. | 33.07M |
| Perspective Therapeutics, Inc. | 31.53M |
| Arcturus Therapeutics Holdings, Inc. | 44.43M |
| Myomo, Inc. | 32.71M |